Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacotherapy for critical limb ischaemia.

L Norgren1

  • 1Department of Vascular Diseases, University Hospital MAS, Malmö, Sweden.

Diabetes/Metabolism Research and Reviews
|October 31, 2000
PubMed
Summary

Critical limb ischaemia management focuses on revascularisation and preventing thrombosis. Pharmacotherapy offers limited solutions for microcirculation issues when revascularisation isn't possible, but can reduce amputations and deaths.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral arterial disease (PAD) - A challenging manifestation of atherosclerosis.

Preventive medicine·2023
Same author

Commentary on 'Peripheral Arterial Disease Incidence and Associated Risk Factors in a Mediterranean Population Based Cohort. The REGICOR Study'.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2016
Same author

Editor's choice. A randomized controlled trial of the fascia suture technique compared with a suture-mediated closure device for femoral arterial closure after endovascular aortic repair.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2015
Same author

Cloxacillin concentrations in serum, subcutaneous fat, and muscle in patients with chronic critical limb ischemia.

European journal of clinical pharmacology·2014
Same author

Response to ‘Statement from the European Society of Vascular Surgery and the World Federation of Vascular Surgery Societies’ Inter-Society Consensus Document (TASC) III and International Standards for Vascular Care (ISVaC).

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2014
Same author

Abdominal hypertension and decompression: the effect on peritoneal metabolism in an experimental porcine study.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2014

Area of Science:

  • Vascular Surgery
  • Pharmacology

Background:

  • Critical limb ischaemia (CLI) presents severe macrocirculation and microcirculation disturbances.
  • Revascularisation (e.g., angioplasty, bypass) is key when feasible.
  • Pharmacological challenges include preventing early thrombosis and midterm hyperplastic growth post-revascularisation.

Purpose of the Study:

  • To outline the pharmacological challenges in managing critical limb ischaemia.
  • To discuss treatment strategies for thrombosis and hyperplastic growth.
  • To explore pharmacotherapy options for microcirculatory events when revascularisation is not possible.

Main Methods:

  • Review of pharmacological interventions for CLI.
  • Analysis of adjuvant treatments for thrombosis.
  • Evaluation of pharmacotherapy for microcirculatory disturbances in unrevascularisable CLI.

Main Results:

  • Adjuvant treatments are effective for early thrombosis post-revascularisation.
  • No specific pharmacological solution currently exists for midterm hyperplastic growth.
  • Pharmacotherapy for microcirculatory events in unrevascularisable CLI yields limited but potentially significant reductions in amputations and deaths.

Conclusions:

  • Effective management of CLI requires addressing both macrocirculatory and microcirculatory aspects.
  • Pharmacological strategies are crucial for preventing complications after revascularisation.
  • Further research is needed for effective treatments of hyperplastic growth and unrevascularisable CLI.

Related Experiment Videos